GGrantIndex
← Leaderboards

David D Eckels

Bloodcenter Of Wisconsin, Inc.

$6,865,097
Attributed
$6,939,137
Total exposure
7
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $769.5K · FY200509
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09

Funding mix

By agency

NIH$6,939,137 · 7

By mechanism

R01$4,601,372 · 2
U19$1,365,335 · 1
P01$819,681 · 1
R03$148,080 · 1
M01$4,669 · 2

Top collaborators

Others in their field

Top investigators on “Helper T Lymphocyte

Research focus

Helper T LymphocyteHepatitis CClinical ResearchHuman SubjectVirus AntigenCytokineImmunoregulationHepatitis C VirusEpitopesLeukocyte Activation /TransformationTissue /Cell CultureHelper-Inducer T-LymphocyteResponseCd4 Positive T LymphocytesT-LymphocyteProductionImmune ResponseChronic Disease /DisorderCellular ImmunityMicroorganism ImmunologyImmuneInterferonsEpitope MappingInterleukin-10

Grant awards (29)

Regulation of human T-cell immunity to HCV antigens$468,931
R01 · FY2009 · AI · contact PI
Regulation of human T-cell immunity to HCV antigens$455,271
R01 · FY2008 · AI · contact PI
Class II Restricted, Influenza Virus Specific T-cells$240,880
U19 · FY2008 · AI · contact PI
T Cell Reactive Epitopes of Shrimp Tropomyosin$73,330
R03 · FY2008 · AI
Regulation of human T-cell immunity to HCV antigens$450,575
R01 · FY2007 · AI · contact PI
Class II Restricted, Influenza Virus Specific T-cells$240,994
U19 · FY2007 · AI · contact PI
T Cell Reactive Epitopes of Shrimp Tropomyosin$74,750
R03 · FY2007 · AI
Regulation of human T-cell immunity to HCV antigens$450,515
R01 · FY2006 · AI · contact PI
Class II Restricted, Influenza Virus Specific T-cells$302,168
U19 · FY2006 · AI · contact PI
REGULATION OF HUMAN T-CELL IMMUNITY TO HCV ANTIGENS$1,288
M01 · FY2006 · RR · contact PI
Class II Restricted, Influenza Virus Specific T-cells$291,784
U19 · FY2005 · AI
Regulation of human T-cell immunity to HCV antigens$223,960
R01 · FY2005 · AI
IMMUNOREGULATORY EFFECTS OF MUTATION IN HCV NS3 ANTIGEN$182,323
R01 · FY2005 · DK
IMMUNOREGULATORY EFFECTS OF MUTATION IN HCV NS3 ANTIGEN$38,177
R01 · FY2005 · DK
REGULATION OF HUMAN T-CELL IMMUNITY TO HCV ANTIGENS$3,381
M01 · FY2005 · RR
Class II Restricted, Influenza Virus Specific T-cells$289,509
U19 · FY2004 · AI
IMMUNOREGULATORY EFFECTS OF MUTATION IN HCV NS3 ANTIGEN$220,500
R01 · FY2004 · DK
REGULATION OF HUMAN T-CELL IMMUNITY TO HCV ANTIGENS$374,514
R01 · FY2003 · AI
IMMUNOREGULATORY EFFECTS OF MUTATION IN HCV NS3 ANTIGEN$220,500
R01 · FY2003 · DK
REGULATION OF HUMAN T-CELL IMMUNITY TO HCV ANTIGENS$332,984
R01 · FY2002 · AI
CORE--SHARED INSTRUMENTATION$273,227
P01 · FY2002 · HL
IMMUNOREGULATORY EFFECTS OF MUTATION IN HCV NS3 ANTIGEN$182,501
R01 · FY2002 · DK
IMMUNOREGULATORY EFFECTS OF MUTATION IN HCV NS3 ANTIGEN$48,111
R01 · FY2002 · DK
CORE--SHARED INSTRUMENTATION$273,227
P01 · FY2001 · HL
IMMUNOREGULATORY EFFECTS OF MUTATION IN HCV NS3 ANTIGEN$251,496
R01 · FY2001 · DK
REGULATION OF HUMAN T-CELL IMMUNITY TO HCV ANTIGENS$179,179
R01 · FY2001 · AI
REGULATION OF HUMAN T-CELL IMMUNITY TO HCV ANTIGENS$176,508
R01 · FY2001 · AI
REGULATION OF HUMAN T-CELL IMMUNITY TO HCV ANTIGENS$345,327
R01 · FY2000 · AI
CORE--SHARED INSTRUMENTATION$273,227
P01 · FY2000 · HL